« As Expected: Merck Drops Gaboxadol, Its Not-Very-Good Sleep Drug | Main | Sanofi in for Rough Ride on Acomplia »

March 29, 2007

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200d83527277569e2

Listed below are links to weblogs that reference Claim: Merck Will Lose $130 Million a Year on Gardasil by Stopping Its Controversial Lobbying:

Comments

John Mack

Jim,

You are not accurately portraying the facts when you say that CDC is taking your position and not your oponents'.

Your position --- and correct if I am wrong -- is that Gardasil vaccination should be MANDATED by the state. That is, it should be required of all girls before they can enroll in grade school.

The CDC merely is making the vaccine available to eligible girls, it is not MANDATING anything. Your readers should read the Merck press release you link to, which says, in part: "Eligible adolescents may receive recommended vaccines through VFC once the CDC contracts for the purchase of the vaccine, a process that is now complete."

Note that the word "may" is not equivalent to "must".

The CDC stance, in fact, is closer to my position than yours; namely, the Gardasil vaccine should be made available to all girls who desire to have it, but vaccinations should not be required by state mandate.

John Mack
Pharma Marketing Blog

Aaron

Aristocort is a corticosteroid used to treat swelling in a number of different disorders such as arthritis, bursitis, or tendonitis. It may also be used to treat asthma, allergic reactions, skin problems, chronic pain, and other conditions. http://www.caldrugs.com/pill/Aristocort.html

Arava is used for reducing signs and symptoms of rheumatoid arthritis. It is also used to improve physical function and to prevent the development of structural damage to the joints. http://www.caldrugs.com/pill/Arava__.html

The comments to this entry are closed.

 
© 2010 Brandweek. All rights reserved. Terms Of Use and Privacy Policy Additional Terms Of Use and Privacy Policy.